Paul Moreton
- Genetics top 1%
- Pathology and Forensic Medicine top 2%
- Immunology top 10%
- Hematology top 5%
- Oncology
- Co-authors
- Peter HillmenAndy C. RawstronBen KennedyChris FeganDavid OscierGuy LucasJane TigheM.J. Leach
- Topics
- Chronic Lymphocytic Leukemia Research (19 papers)Lymphoma Diagnosis and Treatment (15 papers)Immunodeficiency and Autoimmune Disorders (10 papers)
- Partner nations
- United KingdomSwedenSwitzerland
In The Last Decade
Paul Moreton
21 papers receiving 850 citations
Peers
Comparison fields: 5 of 51
- Genetics 712
- Pathology and Forensic Medicine 649
- Immunology 425
- Hematology 160
- Oncology 104
Countries citing papers authored by Paul Moreton
This map shows the geographic impact of Paul Moreton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Moreton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Moreton more than expected).
Fields of papers citing papers by Paul Moreton
This network shows the impact of papers produced by Paul Moreton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Moreton. The network helps show where Paul Moreton may publish in the future.
Co-authorship network of co-authors of Paul Moreton
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Moreton. A scholar is included among the top collaborators of Paul Moreton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Moreton. Paul Moreton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 95 | |
| 2 | 89 | |
| 3 | 4 | |
| 4 | 8 | |
| 5 | 25 | |
| 6 | 28 | |
| 7 | 8 | |
| 8 | 23 | |
| 9 | 29 | |
| 10 | 5 | |
| 11 | 7 | |
| 12 | 293 | |
| 13 | 15 | |
| 14 | 1 | |
| 15 | 14 | |
| 16 | 2 | |
| 17 | 139 | |
| 18 | Achieving a MRD negative response after alemtuzumab for CLL is the best predictor for prolonged survival | 5 |
| 19 | 31 | |
| 20 | 48 |
About Paul Moreton
Paul Moreton is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 21 papers that have together received 872 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (15 papers) and Immunodeficiency and Autoimmune Disorders (10 papers). The work is most often cited by research in Genetics (712 citations), Pathology and Forensic Medicine (649 citations) and Immunology (425 citations). Paul Moreton has collaborated with scholars based in United Kingdom, Sweden and Switzerland. Frequent co-authors include Peter Hillmen, Andy C. Rawstron, Ben Kennedy, Chris Fegan, David Oscier, Guy Lucas, Jane Tighe, M.J. Leach, Saad M. B. Rassam and Andrew Haynes. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.